The intestinal immune response is pivotal in the pathogenesis of IBS, and TGR5 activation can facilitate the release of anti-inflammatory cytokines, thus suppressing the intestinal inflammatory response [411]. The gene discussed is GPBAR1; the disease is irritable bowel syndrome.